Literature DB >> 8711935

Increased serum interleukin-10 level in Kawasaki disease.

D S Kim1, H K Lee, G W Noh, S I Lee, K Y Lee.   

Abstract

Serum IL-10 level in Kawasaki disease(KD) was tested. In the KD patients' sera during the acute phase, the levels of IL-10 were markedly elevated (122.0 +/- 39.1 pg/ml) compared to 3.7 +/- 1.7 pg/ml in the control subjects (p < 0.001). The serum IL-10 levels remained elevated in the subacute phase (16. 7 +/- 9.7 pg/ml, p < 0.001) and were restored to the normal levels(7.9 +/- 3.9 pg/ml) during the convalescent phase. In the patients with acute febrile disease, the serum IL-10 level increased significantly (34.4 +/- 14.1 pg/ml, p < 0.001) compared to that of the age-matched control subjects, but were not as high as in acute phase of KD(p < 0.005). This increase in serum IL-10 levels in KD may contribute to the up-regulation of humoral immunity and to the down-regulation of acute inflammation due to an increase in proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711935     DOI: 10.3349/ymj.1996.37.2.125

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  9 in total

1.  PGK1 as an immune target in Kawasaki disease.

Authors:  J Cui; Y Zhou; H Hu; L Zhao; Z Du; H Du
Journal:  Clin Exp Immunol       Date:  2018-10-15       Impact factor: 4.330

2.  Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.

Authors:  Eisuke Suganuma; Fumio Niimura; Shinichi Matsuda; Toshiko Ukawa; Hideaki Nakamura; Kaori Sekine; Masahiko Kato; Yuji Aiba; Yasuhiro Koga; Kuniyoshi Hayashi; Osamu Takahashi; Hiroyuki Mochizuki
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

Review 3.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

4.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31

5.  Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease.

Authors:  Kai-Chung Hsueh; Ying-Ju Lin; Jeng-Sheng Chang; Lei Wan; Yu-Hsin Tsai; Chang-Hai Tsai; Chih-Ping Chen; Fuu-Jen Tsai
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

Review 6.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

7.  ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.

Authors:  Kyu Yeun Kim; Yoon Sun Bae; Woohyuk Ji; Dongjik Shin; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

8.  Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration.

Authors:  Sung-Chou Li; Kuo-Wang Tsai; Lien-Hung Huang; Ken-Pen Weng; Kuang-Jen Chien; Yuyu Lin; Chi-Ying Tu; Pei-Hsien Lin
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

9.  Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.

Authors:  Ken-Pen Weng; Ching-Feng Cheng; Kuang-Jen Chien; Luo-Ping Ger; Shih-Hui Huang; Kuo-Wang Tsai
Journal:  Curr Issues Mol Biol       Date:  2021-06-25       Impact factor: 2.976

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.